Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials

被引：0
|
作者：
Andrew M. Blumenfeld
Kerry Knievel
Aubrey Manack Adams
Lawrence Severt
Matthew Butler
Hongxin Lai
David W. Dodick
机构：
[1] Headache Center of Southern California,
[2] Barrow Neurological Institute,undefined
[3] AbbVie,undefined
[4] AbbVie,undefined
[5] Mayo Clinic,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Acute treatment; Concomitant therapies; Migraine; Preventive treatment; Ubrogepant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：692 / 705
页数：13
相关论文
共 50 条
  • [41] The effect of doxepin 3 mg on sleep latency: a pooled analysis of two phase 3 trials
    Matt Fisher
    Mako Araga
    Billy Franks
    Andrew Krystal
    Sleep and Breathing, 2025, 29 (2)
  • [42] Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II
    Hutchinson, Susan
    Silberstein, Stephen D.
    Blumenfeld, Andrew M.
    Lipton, Richard B.
    Lu, Kaifeng
    Yu, Sung Yun
    Severt, Lawrence
    CEPHALALGIA, 2021, 41 (09) : 979 - 990
  • [43] Efficacy and safety of lasmiditan in patients on migraine preventive medications: findings from SAMURAI and SPARTAN Phase 3 trials
    Ailani, Jessica
    Loo, Li Shen
    Krege, John H.
    Baygani, Simin
    Hundemer, Hans-Peter
    Port, Martha
    Schim, Jack
    CEPHALALGIA, 2019, 39 : 8 - 8
  • [44] Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Diener, Hans Christoph
    McAllister, Peter
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Silberstein, Stephen D.
    CEPHALALGIA, 2022, 42 (08) : 769 - 780
  • [45] Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    Nahas, Stephanie J.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    Silberstein, Stephen D.
    NEUROLOGY, 2020, 94 (15)
  • [46] Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies
    Vargas, Bert B.
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    McAllister, Peter
    NEUROLOGY, 2020, 94 (15)
  • [47] Safety and Tolerability of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    McAllister, Peter
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    ANNALS OF NEUROLOGY, 2020, 88 : S158 - S159
  • [48] Efficacy of Bempedoic Acid: A Pooled Analysis of 4 Pivotal Phase 3 Clinical Trials
    Banach, Maciej
    Duell, P. Barton
    Gotto, Antonio
    Laufs, Ulrich
    Leiter, Lawrence A.
    Mancini, G. B. J.
    Ray, Kausik K.
    Flaim, JoAnn
    Ye, Zhan
    Catapano, Alberico L.
    CIRCULATION, 2019, 140
  • [49] Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials
    Pinkerton, JoAnn V.
    Pickar, James H.
    Ryan, Kelly A.
    Yu, Ching-Ray
    Mirkin, Sebastian
    Komm, Barry S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (06): : 611 - 620
  • [50] Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials
    Ballantyne, C. M.
    Banach, M.
    Catapano, A. L.
    Duell, P. B.
    Laufs, U.
    Leiter, L. A.
    Mancini, G. B. J.
    Ray, K. K.
    Bloedon, L. T.
    Sasiela, W. J.
    Ye, Z.
    Bays, H. E.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3257 - 3257
12345